Pathogenic drug resistant fungi: a review of mitigation strategies
Fungal pathogens cause significant human morbidity and mortality globally, where there is a
propensity to infect vulnerable people such as the immunocompromised ones. There is …
propensity to infect vulnerable people such as the immunocompromised ones. There is …
Global Prevalence of Antifungal-Resistant Candida parapsilosis: A Systematic Review and Meta-Analysis
A reliable estimate of Candida parapsilosis antifungal susceptibility in candidemia patients
is increasingly important to track the spread of C. parapsilosis bloodstream infections and …
is increasingly important to track the spread of C. parapsilosis bloodstream infections and …
[HTML][HTML] Neonatal Infectious Disease: A Major Contributor to Infant Mortality Requiring Advances in Point-of-Care Diagnosis
M Garvey - Antibiotics, 2024 - mdpi.com
Neonatal infectious disease continues to result in high rates of infant morbidity and mortality.
Early-and late-onset disease represent difficult to detect and difficult to treat illnesses …
Early-and late-onset disease represent difficult to detect and difficult to treat illnesses …
Pseudolaric Acid A: A Promising Antifungal Agent Against Prevalent Non-albicans Candida Species
Z Li, B Zhu, W Chen, J Hu, Y Xue, H Yin… - Infection and Drug …, 2023 - Taylor & Francis
Purpose The non-albicans Candida (NAC) species have recently gained great importance
worldwide due to the increasing proportion in candida causing bloodstream infections. This …
worldwide due to the increasing proportion in candida causing bloodstream infections. This …
Extracellular Vesicles from Candida haemulonii var. vulnera Modulate Macrophage Oxidative Burst
BTM Oliveira, TMH Dourado, PWS Santos… - Journal of Fungi, 2023 - mdpi.com
Members of the Candida haemulonii species complex are multidrug-resistant emergent
yeast pathogens able to cause superficial and invasive infections in risk populations. Fungal …
yeast pathogens able to cause superficial and invasive infections in risk populations. Fungal …
Treatment of invasive candidiasis in the era of Candida resistance
JA Paiva, JM Pereira - Current Opinion in Critical Care, 2023 - journals.lww.com
Avoiding antifungal's overuse and selecting the best drug, dose and duration, when they are
needed, is fundamental. Knowledge of risk factors for resistance, microbiological diagnosis …
needed, is fundamental. Knowledge of risk factors for resistance, microbiological diagnosis …
[HTML][HTML] Biofilm: The invisible culprit in catheter-induced candidemia
Candidemia is the most common form of invasive fungal infection associated with several
risk factors, and one of them is the use of medical devices, to which microbial biofilms can …
risk factors, and one of them is the use of medical devices, to which microbial biofilms can …
Candida albicans and Candida glabrata: global priority pathogens
M Katsipoulaki, MHT Stappers… - Microbiology and …, 2024 - Am Soc Microbiol
SUMMARY A significant increase in the incidence of Candida-mediated infections has been
observed in the last decade, mainly due to rising numbers of susceptible individuals …
observed in the last decade, mainly due to rising numbers of susceptible individuals …
Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak
J Szekely, W Rakchang, P Rattanaphan… - Epidemiology & …, 2023 - cambridge.org
Antifungal susceptibility of Candida species is decreasing. Successful treatment for
antifungal-resistant candida infection is challenging and associated with significant mortality …
antifungal-resistant candida infection is challenging and associated with significant mortality …
Dual-antigen fusion protein vaccination induces protective immunity against Candida albicans infection in mice
K Jia, Y Zhang, M Jiang, M Cui, J Wang… - Human Vaccines & …, 2024 - Taylor & Francis
Candida albicans Is a leading cause of nosocomial bloodstream infections, particularly in
immunocompromised patients. Current therapeutic strategies are insufficient, highlighting …
immunocompromised patients. Current therapeutic strategies are insufficient, highlighting …